Novel drug-eluting stents in the treatment of de novo coronary lesions

References

• HoffmannRMintzGSDussaillantGRPatterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound studyCirculation1996946124712548822976
   PubMed Web of Science ®Google Scholar
• SousaJECostaMAAbizaidACSustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angio-graphic and intravascular ultrasound follow-upCirculation2001104172007201111673337
   PubMed Web of Science ®Google Scholar
• HtayTLiuMWDrug-eluting stent: a review and updateVasc Health Risk Manag20051426327617315599
   PubMedGoogle Scholar
• MoriceMCColomboAMeierBREALITY Trial InvestigatorsSirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trialJAMA2006295889590416493102
   PubMed Web of Science ®Google Scholar
• MillauerNJüniPHofmannASirolimus versus paclitaxel coronary stents in clinical practiceCatheter Cardiovasc Interv201177151220506333
   PubMed Web of Science ®Google Scholar
• AbizaidASirolimus-eluting coronary stents: a reviewVasc Health Risk Manag20073219120117580729
   PubMedGoogle Scholar
• UyanCArincHGunduzHAkdemirRImmediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 studyVasc Health Risk Manag20084117317618629363
   PubMedGoogle Scholar
• KirchnerRMAbbottJDUpdate on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial programVasc Health Risk Manag200951089109720057901
   PubMedGoogle Scholar
• SheibanIVillataGBollatiMSillanoDLotrionteMBiondi-ZoccaiGNext-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Vasc Health Risk Manag200841313818629361
   PubMedGoogle Scholar
• VirmaniRGuagliumiGFarbALocalized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?Circulation2004109670170514744976
   PubMed Web of Science ®Google Scholar
• CamenzindEStegPGWijnsWStent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concernCirculation20071151114401455 discussion 1455.17344324
   PubMed Web of Science ®Google Scholar
• TogniMWindeckerSCocchiaRSirolimus-eluting stents associated with paradoxic coronary vasoconstrictionJ Am Coll Cardiol200546223123616022947
   PubMed Web of Science ®Google Scholar
• JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol200648119320216814667
   PubMed Web of Science ®Google Scholar
• KereiakesDJCannonLAFeldmanRLClinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trialJ Am Coll Cardiol201056426427120493653
   PubMed Web of Science ®Google Scholar
• ChieffoAAranzullaTCColomboADrug eluting stents: focus on Cypher sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesionsVasc Health Risk Manag20073444145117969375
   PubMedGoogle Scholar
• LefèvreTOrmistonJGuagliumiGThe Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesionsJ Am Coll Cardiol200546459259816098421
   PubMed Web of Science ®Google Scholar
• IkenoFKimYHLunaJAcute and long-term outcomes of the novel side access (SLK-View) stent for bifurcation coronary lesions: a multicenter non-randomized feasibility studyCatheter Cardiovasc Interv200667219820616404749
   PubMed Web of Science ®Google Scholar
• OrmistonJWebsterMEl-JackSMcNabDPlaumannSSThe AST petal dedicated bifurcation stent: first-in-human experienceCatheter Cardiovasc Interv200770333534017722036
   PubMed Web of Science ®Google Scholar
• DoiHMaeharaAMintzGSDaniLLeonMBGrubeESerial intravascular ultrasound analysis of bifurcation lesions treated using the novel self-expanding sideguard side branch stentAm J Cardiol200910491216122119840565
   PubMed Web of Science ®Google Scholar
• GrubeEBifurcation and left main dedicated stentsProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• AlbieroRInvatec twin-rail stent: design features and clinical updatesProceedings of TCT2008 Oct 12–17Washington
   Google Scholar
• Van GeunsRJThe Minvasys Nile paclitaxel-eluting sidebranch access stent: results from the BiPAX studyProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• OnumaYMüllerRRamcharitarSTryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesionsEuroIntervention20083554655219608479
   PubMedGoogle Scholar
• IschingerTANew devices for complex vascular interventions. The Y-Med catheter technologyProceedings of Euro PCR2006 May 16–19Paris, France
   Google Scholar
• HermillerJBThe TriReme Medical Antares sidebranch access stent: design specifications and clinical trial resultsProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• SheibanIOmedéPBiondi-ZoccaiGMorettiCSciutoFTreviGPUpdate on dedicated bifurcation stentsJ Interv Cardiol200922215015519379474
   PubMed Web of Science ®Google Scholar
• GrubeEBuellesfeldLNeumannFJSix-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowingsAm J Cardiol200799121691169717560877
   PubMed Web of Science ®Google Scholar
• VerheyeSAgostoniPDuboisCL9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) studyJ Am Coll Cardiol200953121031103919298915
   PubMed Web of Science ®Google Scholar
• OrmistonJALefèvreTGrubeEAlloccoDJDawkinsKDFirst human use of the TAXUS Petal paclitaxel-eluting bifurcation stentEuroIntervention201061465320542797
   PubMed Web of Science ®Google Scholar
• Van GeunsRJThe Minvasys Nile paclitaxel-eluting sidebranch access stent: design specifications and clinical trial resultsProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• CostaRABIPAX bifurcation study: first resultsProceedings of Euro PCR2010 May 25–28Paris, France
   Google Scholar
• VerheyeSGrubeERamcharitarSFirst-in-man (FIM) study of the Stentys bifurcation stent – 30 days resultsEuroIntervention20094556657119378675
   PubMed Web of Science ®Google Scholar
• VerheyeSLatest results of the STENTYS clinical programmeProceedings of Euro PCR2010 May 25–28Paris, France
   Google Scholar
• Van GeunsRJAPPOSITION II study resultsProceedings of TCT2010 Sep 21–25Washington
   Google Scholar
• RathoreSSmall coronary vessel angioplasty: outcomes and technical considerationsVasc Health Risk Manag2010691592221057576
   PubMedGoogle Scholar
• TanimotoSDaemenJSerruysPWUpdate on stents: recent studies on the TAXUS stent system in small vesselsVasc Health Risk Manag20073448149017969378
   PubMedGoogle Scholar
• AbizaidACde Ribamar CostaJJuniorWhitbournRJChangJCThe CardioMind coronary stent delivery system: stent delivery on a 0.014″ guidewire platformEuroIntervention20073115415719737701
   PubMedGoogle Scholar
• WhitbournRJThe CARDIOMIND stent-on-a-wire self-expanding micro-stent: results from CARE I (two year follow-up) and introduction to CARE II (sirolimus-eluting micro-stent)Proceedings of TCT2008 Oct 12–17Washington
   Google Scholar
• BotelhoRThe Cardiomind Sparrow DES program (CARE II): a bioabsorbable polymer sirolimus-eluting ‘micro-stent’Proceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• AbizaidACCARE II 8 month follow-up results with the CardioMind 0.014″ Sparrow sirolimus-eluting nitinol stent systemJ Am Coll Cardiol201056B53
   Web of Science ®Google Scholar
• MeredithITWorthleySWhitbournRRESOLUTE InvestigatorsClinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trialJACC Cardiovasc Interv200921097798519850258
   PubMed Web of Science ®Google Scholar
• UdipiKMelderRJChenMThe next generation Endeavor Resolute Stent: role of the BioLinx Polymer SystemEuroIntervention20073113713919737697
   PubMedGoogle Scholar
• MeredithITWorthleySGWhitbournRLong-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trialEuroIntervention20105669269720142220
   PubMed Web of Science ®Google Scholar
• SilberSRESOLUTE: new insights from resolute all-comersProceedings of TCT2010 Sep 21–25Washington
   Google Scholar
• DaniSKukrejaNParikhPBiodegradable-polymer-based, sirolimus-eluting Supralimus stent: 6-month angiographic and 30-month clinical follow-up results from the series I prospective studyEuroIntervention200841596319112780
   PubMedGoogle Scholar
• CostaJSupralimus bioabsorbable-polymer sirolimus-eluting stent technology in patients with acute coronary syndrome undergoing percutaneous coronary intervention: initial results of the prospective, international, multicenter, E-SERIES registryProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• HanYJingQXuBCREATE (Multi-Center Registry of Excel Biodegradable Polymer Drug-Eluting Stents) InvestigatorsSafety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in ‘real-world’ practice: 18-month clinical and 9-month angiographic outcomesJACC Cardiovasc Interv20092430330919463441
   PubMed Web of Science ®Google Scholar
• FaloticoRParkerTGrishaberRPriceSCohenSARogersCNEVO™: a new generation of sirolimus-eluting coronary stentEuroIntervention20095Suppl FF88F93
   PubMedGoogle Scholar
• SpauldingCOrmistonJAAbizaidAon behalf of the NEVO RES-I Investigators6 Months results of the NEVO RES-ELUTION I (RES-I) trial. A randomized, multi-center, single-blind comparison of the NEVO™ sirolimus-eluting coronary stent versus the TAXUS™ Liberté paclitaxel-eluting coronary stent system in de novo native coronary artery lesionsProceedings of Euro PCR2009 May 19–22Barcelona, Spain
   Google Scholar
• MauriLon behalf of NEVO RES-I InvestigatorsNEVO RES-elution trial – 12-month results and pivotal trial overviewProceedings of TCT2010 Sep 21–25Washington
   Google Scholar
• VranckxPSerruysPWGambhirSBiodegradable-polymer-based, paclitaxel-eluting infinnium stent: 9-month clinical and angio-graphic follow-up results from the SIMPLE II prospective multi-centre registry studyEuroIntervention20062331031719755306
   PubMedGoogle Scholar
• LemosPAMoulinBPerinMAPAINT Trial InvestigatorsRandomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trialCatheter Cardiovasc Interv200974566567319670303
   PubMed Web of Science ®Google Scholar
• GuagliumiGValsecchiOAprileAJACTAX paclitaxel-eluting stent program. Ultra-thin abluminal PLA polymer. Focus on the randomized OCTDESI strut coverage evaluationProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• GuagliumiGSirbuVMusumeciGStrut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI)Circ Cardiovasc Interv20103436737520647562
   PubMed Web of Science ®Google Scholar
• TurcoMAOrmistonJAPopmaJJPolymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trialJ Am Coll Cardiol200749161676168317448368
   PubMed Web of Science ®Google Scholar
• GrubeESchoferJHauptmannKEA novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stentJACC Cardiovasc Interv20103443143820398872
   PubMed Web of Science ®Google Scholar
• SerruysPWSianosGAbizaidAThe effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)J Am Coll Cardiol200546225326016022951
   PubMed Web of Science ®Google Scholar
• KaulUGuptaRKMathurACobalt chromium stent with anti-proliferative for restenosis trial in India (COSTAR I)Indian Heart J200759216517219122251
   PubMedGoogle Scholar
• DawkinsKDVerheyeSSchühlenHThe European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month resultsEuroIntervention200731828819737689
   PubMedGoogle Scholar
• KrucoffMWKereiakesDJPetersenJLCOSTAR II Investigators GroupA novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyJ Am Coll Cardiol200851161543155218420096
   PubMed Web of Science ®Google Scholar
• WesselyRHausleiterJMichaelisCInhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coatingArterioscler Thromb Vasc Biol200525474875315681298
   PubMed Web of Science ®Google Scholar
• HausleiterJKastratiAWesselyRInvestigators of the Individualizable Drug-Eluting Stent System to Abrogate Restenosis ProjectPrevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coatingEur Heart J200526151475148115975990
   PubMed Web of Science ®Google Scholar
• MehilliJKastratiAWesselyRIntracoronary Stenting and Angiographic Restenosis–Test Equivalence Between 2 Drug-Eluting Stents (ISAR-TEST) Trial InvestigatorsRandomized trial of a non-polymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen lossCirculation2006113227327916391155
   PubMed Web of Science ®Google Scholar
• FitzgeraldPCommentary: ISAR test 3Proceedings of TCT2008 Oct 12–17Washington
   Google Scholar
• RuefJStorgerHSchwarzFHaaseJComparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesionsCatheter Cardiovasc Interv200871333333918288747
   PubMed Web of Science ®Google Scholar
• ByrneRAIijimaRMehilliJDurability of antirestenotic efficacy in drug-eluting stents with and without permanent polymerJACC Cardiovasc Interv20092429129919463439
   PubMed Web of Science ®Google Scholar
• GrubeEBIOFREEDOM: a prospective randomized trial of polymer-free biolimus a9-eluting stents and paclitaxel-eluting stents in patients with coronary artery diseaseProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• TadaNVirmaniRGrantGPolymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine modelCirc Cardiovasc Interv20103217418320407114
   PubMed Web of Science ®Google Scholar
• FajadetJThe Minvasys Amazonia PAX and Nile PAX polymer free paclitaxel eluting stent programProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• AbizaidAPAX A trial: 4-months follow-up resultsProceedings of Euro PCR2010 May 25–28Paris, France
   Google Scholar
• CostaJRJrAbizaidACostaR1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trialJACC Cardiovasc Interv20092542242719463465
   PubMed Web of Science ®Google Scholar
• AbizaidAVESTAsync I update, and First Report of the VESTAsync II randomized trial with a hydroxyapatite polymer-free sirolimus-eluting stentProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• VerheyeSAgostoniPDawkinsKDThe GENESIS (Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries) trialJACC Cardiovasc Interv20092320521419463427
   PubMed Web of Science ®Google Scholar
• CostaJRJrAbizaidAFeresFEXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesionsEuroIntervention200841535819112779
   PubMedGoogle Scholar
• SerruysPWGargSAbizaidAA randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyEuroIntervention20106219520520562069
   PubMed Web of Science ®Google Scholar
• GargSSarnoGSerruysPWThe twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymerEuroIntervention20106223323920562074
   PubMed Web of Science ®Google Scholar
• KlaussVLEADERS: two-year follow-up from a prospective randomized trial of biolimus A9-eluting stents with a bioabsorbable polymer vs. sirolimus-eluting stents with a durable polymerProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• EstevesVAbizaidACentemeroMPFive-year clinical results of the biolimus A9 eluting stent with biodegradable polymerProceedings of Euro PCR2010 May 25–28Paris, France
   Google Scholar
• OstojicMSagicDBeleslinBFirst clinical comparison of Nobori-Biolimus A9 eluting stents with Cypher-Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomesEuroIntervention20083557457919608483
   PubMedGoogle Scholar
• ChevalierBSilberSParkSJNOBORI 1 Clinical InvestigatorsRandomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial – Phase 2Circ Cardiovasc Interv20092318819520031715
   PubMed Web of Science ®Google Scholar
• HamilosMIOstojicMBeleslinBNOBORI CORE InvestigatorsDifferential effects of drug-eluting stents on local endothelium-dependent coronary vasomotionJ Am Coll Cardiol200851222123212918510958
   PubMed Web of Science ®Google Scholar
• RutschWWitzenbichlerBSchuhlenHMulticentre first-in-man study with the lowest known limus dose on the Elixir medical myolimus™ eluting coronary stent system with a durable polymer: 12-month clinical and six month angiographic and IVUS follow-upProceedings of Euro PCR2009 May 19–22Barcelona, Spain
   Google Scholar
• SchoeferJDudekDWitzenbichlerBMulticenter, first-in-man study on the Elixir Myolimus-eluting coronary stent system with bio-absorbable polymer: 12-month clinical and angiographic/IVUS resultsProceedings of Euro PCR2010 May 25–28Paris, France
   Google Scholar
• WykrzykowskaJJOnumaYSerruysPWAdvances in stent drug delivery: the future is in bioabsorbable stentsExpert Opin Drug Deliv20096211312619239384
   PubMed Web of Science ®Google Scholar
• OrmistonJASerruysPWBioabsorbable coronary stentsCirc Cardiovasc Interv20092325526020031723
   PubMed Web of Science ®Google Scholar
• OrmistonJASerruysPWRegarEA bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trialLancet2008371961689990718342684
   PubMed Web of Science ®Google Scholar
• SerruysPWOrmistonJAOnumaYA bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methodsLancet2009373966789791019286089
   PubMed Web of Science ®Google Scholar
• OrmistonJABVS cohort A: four year results and lessons learnedProceedings of TCT2010 Sep 21–25Washington
   Google Scholar
• TanimotoSSerruysPWThuesenLComparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trialsCatheter Cardiovasc Interv200770451552317503509
   PubMed Web of Science ®Google Scholar
• García-GarcíaHMGonzaloNPawarRAssessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A sub-study of the ABSORB clinical trialEuroIntervention20094444344819284065
   PubMed Web of Science ®Google Scholar
• SarnoGOnumaYGarcia GarciaHMIVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption processCatheter Cardiovasc Interv201075691491820091822
   PubMed Web of Science ®Google Scholar
• OkamuraTGargSGutiérrez-ChicoJLIn vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trialEuroIntervention20105893293820542778
   PubMed Web of Science ®Google Scholar
• SerruysPWBVS cohort B: device design, 6-month update, and first report of the 12-month resultsProceedings of TCT2010 Sep 21–25Washington
   Google Scholar
• KaluzaGLCurrent status of polymeric biodegradable drug eluting stents II: REVA Medical, IncProceedings of TCT2006 Oct 22–27Washington
   Google Scholar
• GrubeEThe REVA tyrosine-derived polycarbonate bioabsorbable stent: final results from the RESORB first-in-man clinical trial and next generation designsProceedings of TCT2008 Oct 12–17Washington
   Google Scholar
• PollmanMJEngineering a bioresorbable stent: REVA programme updateEuroIntervention20095Suppl FF54F57
   PubMedGoogle Scholar
• AbizaidAThe REVA tyrosine-derived polycarbonate bioabsorbable stent: lessons learned and future directionsProceedings of TCT2009 Sep 21–25San Francisco
   Google Scholar
• JabaraRPendyalaLGevaSChenJChronosNRobinsonKNovel fully bioabsorbale salicylate-based sirolimuseluting stentEuroIntervention20095Suppl FF58F64
   PubMedGoogle Scholar
• AbizaidAThe BTI salycilate-based polyanhydride ester absorbable sirolimus-eluting stent: update from the Whisper studyProceedings of TCT2008 Oct 12–17Washington
   Google Scholar
• JabaraRPoly-anhydride based on salicylic acid and adipic acid anhydrideProceedings of Euro PCR2009 May 19–22Barcelona, Spain
   Google Scholar
• TamaiHIgakiKKyoEInitial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humansCirculation2000102439940410908211
   PubMed Web of Science ®Google Scholar
• NishioSLong-term (>10 years) clinical outcomes of first-in-man biodegradable poly-l-lactic acid coronary stentsProceedings of Euro PCR2010 May 25–28Paris, France
   Google Scholar
• OnumaYGargSOkamuraTTen-year follow-up of the IGAKI–TAMAI stent. A posthumous tribute to the scientific work of Dr. Hideo TamaiEuroIntervention20095Suppl FF109F111
   PubMedGoogle Scholar
• VogtFSteinARettemeierGLong-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stentEur Heart J200425151330134015288161
   PubMed Web of Science ®Google Scholar
• HeubleinBRohdeRKaeseVNiemeyerMHartungWHaverichABiocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?Heart200389665165612748224
   PubMed Web of Science ®Google Scholar
• ErbelRDi MarioCBartunekJPROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) InvestigatorsTemporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trialLancet200736995761869187517544767
   PubMed Web of Science ®Google Scholar
• WaksmanRCurrent state of the absorbable metallic (magnesium) stentEuroIntervention20095Suppl FF94F98
   PubMedGoogle Scholar